Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 3
1965 1
1966 3
1967 5
1968 6
1969 4
1970 8
1971 3
1972 3
1973 1
1975 3
1976 1
1978 5
1979 3
1980 2
1981 2
1982 6
1983 6
1984 3
1985 2
1986 3
1987 3
1988 1
1989 4
1990 3
1991 2
1992 5
1993 5
1994 5
1995 2
1996 4
1997 5
1998 6
2000 3
2001 4
2002 2
2003 1
2004 3
2005 4
2006 11
2007 15
2008 20
2009 16
2010 11
2011 8
2012 10
2013 5
2014 18
2015 14
2016 21
2017 29
2018 19
2019 30
2020 38
2021 35
2022 57
2023 59
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

517 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant EGFR-TKI therapy in Non-Small cell lung cancer.
Grant C, Nagasaka M. Grant C, et al. Among authors: nagasaka m. Cancer Treat Rev. 2024 May;126:102724. doi: 10.1016/j.ctrv.2024.102724. Epub 2024 Mar 27. Cancer Treat Rev. 2024. PMID: 38636443 Free article. Review.
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial.
Smit EF, Felip E, Uprety D, Nagasaka M, Nakagawa K, Paz-Ares Rodríguez L, Pacheco JM, Li BT, Planchard D, Baik C, Goto Y, Murakami H, Saltos A, Pereira K, Taguchi A, Cheng Y, Yan Q, Feng W, Tsuchihashi Z, Jänne PA. Smit EF, et al. Among authors: nagasaka m. Lancet Oncol. 2024 Apr;25(4):439-454. doi: 10.1016/S1470-2045(24)00064-0. Lancet Oncol. 2024. PMID: 38547891 Clinical Trial.
ID3 is a novel target gene of p53 and modulates lung cancer cell metastasis.
Nagasaka M, Miyajima C, Inoue Y, Hashiguchi S, Suzuki Y, Morishita D, Aoki H, Toriuchi K, Katayama R, Aoyama M, Hayashi H. Nagasaka M, et al. Biochem Biophys Res Commun. 2024 May 14;708:149789. doi: 10.1016/j.bbrc.2024.149789. Epub 2024 Mar 16. Biochem Biophys Res Commun. 2024. PMID: 38513475
517 results